FPS
RMD icon

Fieldpoint Private Securities’s ResMed RMD Stock Holding History

Fieldpoint Private Securities’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$443K Sell
2,111
-327
-13% -$69.6K 0.13% 162
2022
Q1 		$591K Buy
2,438
+287
+13% +$69.4K 0.12% 182
2021
Q4 		$560K Sell
2,151
-44
-2% -$11.4K 0.11% 196
2021
Q3 		$578K Sell
2,195
-25
-1% -$6.84K 0.13% 177
2021
Q2 		$611K Sell
2,220
-19
-0.8% -$3.99K 0.13% 177
2021
Q1 		$434K Sell
2,239
-553
-20% -$111K 0.1% 212
2020
Q4 		$593K Buy
2,792
+295
+12% +$58.8K 0.13% 166
2020
Q3 		$428K Sell
2,497
-53
-2% -$9.79K 0.13% 175
2020
Q2 		$490K Sell
2,550
-3,044
-54% -$498K 0.17% 152
2020
Q1 		$824K Sell
5,594
-73
-1% -$11.6K 0.32% 97
2019
Q4 		$878K Buy
5,667
+298
+6% +$43K 0.26% 112
2019
Q3 		$725K Sell
5,369
-710
-12% -$93K 0.26% 114
2019
Q2 		$741K Buy
+6,079
New +$673K 0.23% 123

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Fieldpoint Private Securities's RMD Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its ResMed (RMD) stake by 13% in Q2 2022, selling an estimated $69.6K and leaving 2,111 shares worth $443K. The position accounts for 0.13% of the portfolio, ranked #162.

Fieldpoint Private Securities first reported a position in RMD in Q2 2019 and has held it in 13 quarters since. The position peaked at $878K in Q4 2019. 677 funds tracked by Wall St. Rank hold RMD as of Q2 2022.

  • Fieldpoint Private Securities held 2,111 shares of ResMed worth $443K as of Q2 2022.
  • Fieldpoint Private Securities sold 327 ResMed shares in Q2 2022, an estimated $69.6K.
  • ResMed made up 0.13% of Fieldpoint Private Securities's portfolio in Q2 2022, its #162 holding.
  • Fieldpoint Private Securities first reported a position in ResMed in Q2 2019 and has held it in 13 quarters since.
  • Fieldpoint Private Securities's ResMed position peaked at $878K in Q4 2019.
  • 677 funds tracked by Wall St. Rank held ResMed as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.